Dlk Investment Management, LLC Adc Therapeutics Sa Transaction History
Dlk Investment Management, LLC
- $239 Billion
- Q1 2025
A detailed history of Dlk Investment Management, LLC transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Dlk Investment Management, LLC holds 26,805 shares of ADCT stock, worth $76,394. This represents 0.02% of its overall portfolio holdings.
Number of Shares
26,805
Previous 25,805
3.88%
Holding current value
$76,394
Previous $51.4 Million
26.4%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding ADCT
# of Institutions
84Shares Held
53.9MCall Options Held
5KPut Options Held
7.6K-
Redmile Group, LLC San Francisco, CA15.7MShares$44.7 Million2.32% of portfolio
-
Prosight Management, LP Dallas, TX9.54MShares$27.2 Million4.79% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.97MShares$17 Million0.26% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$10.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.02MShares$8.61 Million0.0% of portfolio
About ADC Therapeutics SA
- Ticker ADCT
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,645,296
- Market Cap $221M
- Description
- ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...